Neve KA - Search Results

1

Mutation of three residues in the third intracellular loop of the dopamine D2 receptor creates an internalization-defective receptor.

Clayton CC, Donthamsetti P, Lambert NA, Javitch JA, Neve KA. Clayton CC, et al. Among authors: neve ka. J Biol Chem. 2014 Nov 28;289(48):33663-75. doi: 10.1074/jbc.M114.605378. Epub 2014 Oct 21. J Biol Chem. 2014. PMID: 25336643 Free PMC article.

2

Contributions of conserved serine residues to the interactions of ligands with dopamine D2 receptors.

Cox BA, Henningsen RA, Spanoyannis A, Neve RL, Neve KA. Cox BA, et al. Among authors: neve rl, neve ka. J Neurochem. 1992 Aug;59(2):627-35. doi: 10.1111/j.1471-4159.1992.tb09416.x. J Neurochem. 1992. PMID: 1321233

3

Dopamine D2 receptor stimulation of Na+/H+ exchange assessed by quantification of extracellular acidification.

Neve KA, Kozlowski MR, Rosser MP. Neve KA, et al. J Biol Chem. 1992 Dec 25;267(36):25748-53. J Biol Chem. 1992. PMID: 1361188 Free article.

4

Coupling of a cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion.

Albert PR, Neve KA, Bunzow JR, Civelli O. Albert PR, et al. Among authors: neve ka. J Biol Chem. 1990 Feb 5;265(4):2098-104. J Biol Chem. 1990. PMID: 1688845 Free article.

5

Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase.

Neve KA, Cox BA, Henningsen RA, Spanoyannis A, Neve RL. Neve KA, et al. Among authors: neve rl. Mol Pharmacol. 1991 Jun;39(6):733-9. Mol Pharmacol. 1991. PMID: 1828858

6

Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction.

Kozell LB, Machida CA, Neve RL, Neve KA. Kozell LB, et al. Among authors: neve rl, neve ka. J Biol Chem. 1994 Dec 2;269(48):30299-306. J Biol Chem. 1994. PMID: 7982941 Free article.

7

Constitutive activity of a chimeric D2/D1 dopamine receptor.

Kozell LB, Neve KA. Kozell LB, et al. Among authors: neve ka. Mol Pharmacol. 1997 Dec;52(6):1137-49. doi: 10.1124/mol.52.6.1137. Mol Pharmacol. 1997. PMID: 9396784

8

Modeling and mutational analysis of a putative sodium-binding pocket on the dopamine D2 receptor.

Neve KA, Cumbay MG, Thompson KR, Yang R, Buck DC, Watts VJ, DuRand CJ, Teeter MM. Neve KA, et al. Mol Pharmacol. 2001 Aug;60(2):373-81. doi: 10.1124/mol.60.2.373. Mol Pharmacol. 2001. PMID: 11455025

9

Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer.

Canals M, Marcellino D, Fanelli F, Ciruela F, de Benedetti P, Goldberg SR, Neve K, Fuxe K, Agnati LF, Woods AS, Ferré S, Lluis C, Bouvier M, Franco R. Canals M, et al. J Biol Chem. 2003 Nov 21;278(47):46741-9. doi: 10.1074/jbc.M306451200. Epub 2003 Aug 21. J Biol Chem. 2003. PMID: 12933819 Free article.

10

Preferential Interaction between the dopamine D2 receptor and Arrestin2 in neostriatal neurons.

Macey TA, Gurevich VV, Neve KA. Macey TA, et al. Among authors: neve ka. Mol Pharmacol. 2004 Dec;66(6):1635-42. doi: 10.1124/mol.104.001495. Epub 2004 Sep 10. Mol Pharmacol. 2004. PMID: 15361545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters